Dr. Reddy’s, Shanghai Henlius Biotech ink $131.6 million cancer drug deal
Dr. Reddy’s Laboratories will develop and commercialise Shanghai Henlius Biotech’s biosimilar candidate to Johnson & Johnson’s multiple myeloma drugs Darzalex and Darzalex Faspro. It will get exclusive rights to commercialise…